| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |